Press Release
Phibro Animal Health Corporation and Zydus Cadila announce their intention to license Phibro's Poultry Vaccine Technologies05-07-2017
05-07-2017
Press Release
Zydus starts phase II trial of ZYAN1 for treating anemia in patients with CKD.05-07-2017
Zydus Cadila gets USFDA nod for anti-diabetic drug
Cadila Healthcare Ltd (Zydus Cadila), on Tuesday, said it has received tentative approval from the USFDA to market Sitagliptin and Metformin Hydrochloride tablets in the strengths of 50 mg/500mg and...04-07-2017
Press Release
Zydus receives tentative approval from the USFDA for Sitagliptin and Metformin Hydrochloride Tablets04-07-2017
Zydus Cadila gets USFDA nod to market anti-obesity drug
Zydus Cadila has received approval from the US health regulator to market Phentermine Hydrochloride orally disintegrating tablets used for the treatment of obesity in the American market. The...30-06-2017
Press Release
Zydus receives final approval from the USFDA for Phentermine Hydrochloride Orally Disintegrating Tablets.30-06-2017
Press Release
Zydus' Nesher Pharmaceuticals gets USFDA final approval for Dextroamphetamine Sulfate Extended-Release Capsules29-06-2017
Troubles behind it, Cadila surges ahead
Cadila hopes to double its revenue from the US in three years28-06-2017
Press Release
Zydus receives final approval from the USFDA for Oxybutynin Chloride Extended-Release Tablets28-06-2017